Tuesday, November 24, 2009, 3:56am EST - Canadian Markets open in 5 hours and 34 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Cytokinetics Inc. (CYTK)

 On Nov 23: 3.48 USD   0.00 (0.00%)  
MORE ON CYTK
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Cytokinetics, Incorporated (NGM:CYTK) Delayed quote dataEdit
Last Trade: 3.48 USD
Trade Time: Nov 23
Change: 0.00 (0.00%)
Prev Close: 3.48
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 10.38
Day's Range: N/A - N/A
52wk Range: 1.39 - 5.55
Volume: 0
Avg Vol (3m): 590,589
Market Cap: 212.03M
P/E (ttm): 7.28
EPS (ttm): 0.48
Div & Yield: N/A (N/A%)
Cytokinetics Inc. (CYTK)
1d  5d  3m  6m  1y  2y  5y  max 
 Add CYTK to Portfolio   Download Data

HEADLINES
• CYTOKINETICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Nov 19)
• Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 Presented at the 2009 AACR-NCI-EORTC International Conference
Marketwire (Thu, Nov 19)
• Coverage initiated on Cytokinetics by Canaccord Adams
Briefing.com (Wed, Nov 18)
• CYTOKINETICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Nov 17)
• Cytokinetics Presents Non-Clinical Data From Its Smooth Muscle Contractility Program at the 2009 Scientific Sessions of the American Heart Association
Marketwire (Tue, Nov 17)
• Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 to Be Presented at the 2009 AACR-NCI-EORTC International Conference
Marketwire (Thu, Nov 12)
• Cytokinetics' Market Potential
at Seeking Alpha (Thu, Nov 12)
• CYTOKINETICS INC Financials
EDGAR Online Financials (Wed, Nov 11)
• Cytokinetics to Present Non-Clinical Data From Its Smooth Muscle Contractility Program at the 2009 Scientific Sessions of the American Heart Association
Marketwire (Tue, Nov 10)
• Cytokinetics starts test of muscle drug
at bizjournals.com (Mon, Nov 9)
• CYTOKINETICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Mon, Nov 9)
More Headlines for CYTK...
ANALYST
EPS Est (next year) (Dec-09) : 0.44
EPS Est (in 2 years) (Dec-10) : -0.75
Avg Rec (current)*: 1.8
PEG Ratio: 0.52
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Cytokinetics, Incorporated, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule drug therapeutics for the treatment of cardiovascular diseases and cancer.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices